Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::404367469.png) @EgidiusLambrech E Lambrechts

E Lambrechts posts on X about $gmab, $abbv, checkpoint, approved the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

### Engagements: XXX [#](/creator/twitter::404367469/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:interactions.svg)

- X Week XXX +281%
- X Month XXX -XX%
- X Months XXXXXX -XX%
- X Year XXXXXX +25%

### Mentions: XX [#](/creator/twitter::404367469/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:posts_active.svg)


### Followers: XXX [#](/creator/twitter::404367469/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:followers.svg)

- X Week XXX +3.20%
- X Month XXX +3.80%
- X Months XXX +6.90%
- X Year XXX -XX%

### CreatorRank: undefined [#](/creator/twitter::404367469/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::404367469/c:line/m:influencer_rank.svg)

### Social Influence [#](/creator/twitter::404367469/influence)
---

**Social category influence**
[stocks](/list/stocks) 

**Social topic influence**
[$gmab](/topic/$gmab), [$abbv](/topic/$abbv), [checkpoint](/topic/checkpoint), [approved](/topic/approved), [$jnj](/topic/$jnj), [$halo](/topic/$halo), [$fro](/topic/$fro)

**Top assets mentioned**
[AbbVie Inc (ABBV)](/topic/$abbv) [Johnson & Johnson (JNJ)](/topic/$jnj) [Halozyme Therapeutics, Inc. (HALO)](/topic/$halo) [Frontline Ltd. (FRO)](/topic/$fro)
### Top Social Posts [#](/creator/twitter::404367469/posts)
---
Top posts by engagements in the last XX hours

"New #Genmab trial: Study of the Effectiveness and Safety of #Acasunlimab Alone and With Pembrolizumab to Treat Advanced #Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) $GMAB"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1925555019371192368) 2025-05-22 14:11:06 UTC XXX followers, XXX engagements


"@BertrandBio it is exactly one of the points Genmab's Jan van de Winkel made when promoting Hexabody-CD38 in one of his conference calls; wouldn't it be fun if JNJ were to reconsider their decision to opt-out of Hexa-CD38 😂"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1922701797832937685) 2025-05-14 17:13:25 UTC XXX followers, XXX engagements


"#DARZALEX (daratumumab) receives the first positive #CHMP opinion for patients with high-risk #smouldering multiple myeloma $JNJ $GMAB #Genmab $HALO #EMA"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1936011823196553444) 2025-06-20 10:42:42 UTC XXX followers, XXX engagements


"#Acasunlimab + PD-1 Blockade: Combining Forces to Boost Anti-Tumor Immunotherapy @Genmab $GMAB #GEN1046 #DuoBody-PD-L1x4-1BB"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1922546897463435448) 2025-05-14 06:57:54 UTC XXX followers, XXX engagements


"Phase III trial of #rinatabart sesutecan in platinum-resistant ovarian cancer #Genmab $GMAB Rina-S @AngelesSecord"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1942501543065878884) 2025-07-08 08:30:32 UTC XXX followers, XXX engagements


"#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935633294336594402) 2025-06-19 09:38:34 UTC XXX followers, 1155 engagements


"#Acasunlimab an Fc-inert PD-L14-1BB bispecific antibody combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects $GMAB #Genmab #DuoBody #GEN1046"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1911775214494511503) 2025-04-14 13:35:04 UTC XXX followers, XXX engagements


"Results from EPCORE NHL-2 trial of #epcoritamab + R-CHOP for previously untreated DLBCL #Genmab $GMAB #AbbVie $ABBV #Epkinly #ICML2025"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935625131826745706) 2025-06-19 09:06:08 UTC XXX followers, 1119 engagements


"FDA rejects new indication for Columvi Roche Genentech $ABBV $GMAB AbbVie Genmab #Epkinly #Epcoritamab via @onclive"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1947207891301073191) 2025-07-21 08:11:53 UTC XXX followers, XXX engagements


"#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025"  
![@EgidiusLambrech Avatar](https://lunarcrush.com/gi/w:16/cr:twitter::404367469.png) [@EgidiusLambrech](/creator/x/EgidiusLambrech) on [X](/post/tweet/1935633437366645173) 2025-06-19 09:39:08 UTC XXX followers, 1108 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@EgidiusLambrech Avatar @EgidiusLambrech E Lambrechts

E Lambrechts posts on X about $gmab, $abbv, checkpoint, approved the most. They currently have XXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

  • X Week XXX +281%
  • X Month XXX -XX%
  • X Months XXXXXX -XX%
  • X Year XXXXXX +25%

Mentions: XX #

Mentions Line Chart

Followers: XXX #

Followers Line Chart

  • X Week XXX +3.20%
  • X Month XXX +3.80%
  • X Months XXX +6.90%
  • X Year XXX -XX%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence #


Social category influence stocks

Social topic influence $gmab, $abbv, checkpoint, approved, $jnj, $halo, $fro

Top assets mentioned AbbVie Inc (ABBV) Johnson & Johnson (JNJ) Halozyme Therapeutics, Inc. (HALO) Frontline Ltd. (FRO)

Top Social Posts #


Top posts by engagements in the last XX hours

"New #Genmab trial: Study of the Effectiveness and Safety of #Acasunlimab Alone and With Pembrolizumab to Treat Advanced #Melanoma of the Skin That Has Returned After Treatment With an Approved Checkpoint Inhibitor Therapy (ABBIL1TY MELANOMA-07) $GMAB"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-05-22 14:11:06 UTC XXX followers, XXX engagements

"@BertrandBio it is exactly one of the points Genmab's Jan van de Winkel made when promoting Hexabody-CD38 in one of his conference calls; wouldn't it be fun if JNJ were to reconsider their decision to opt-out of Hexa-CD38 😂"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-05-14 17:13:25 UTC XXX followers, XXX engagements

"#DARZALEX (daratumumab) receives the first positive #CHMP opinion for patients with high-risk #smouldering multiple myeloma $JNJ $GMAB #Genmab $HALO #EMA"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-06-20 10:42:42 UTC XXX followers, XXX engagements

"#Acasunlimab + PD-1 Blockade: Combining Forces to Boost Anti-Tumor Immunotherapy @Genmab $GMAB #GEN1046 #DuoBody-PD-L1x4-1BB"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-05-14 06:57:54 UTC XXX followers, XXX engagements

"Phase III trial of #rinatabart sesutecan in platinum-resistant ovarian cancer #Genmab $GMAB Rina-S @AngelesSecord"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-07-08 08:30:32 UTC XXX followers, XXX engagements

"#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-06-19 09:38:34 UTC XXX followers, 1155 engagements

"#Acasunlimab an Fc-inert PD-L14-1BB bispecific antibody combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects $GMAB #Genmab #DuoBody #GEN1046"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-04-14 13:35:04 UTC XXX followers, XXX engagements

"Results from EPCORE NHL-2 trial of #epcoritamab + R-CHOP for previously untreated DLBCL #Genmab $GMAB #AbbVie $ABBV #Epkinly #ICML2025"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-06-19 09:06:08 UTC XXX followers, 1119 engagements

"FDA rejects new indication for Columvi Roche Genentech $ABBV $GMAB AbbVie Genmab #Epkinly #Epcoritamab via @onclive"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-07-21 08:11:53 UTC XXX followers, XXX engagements

"#Genmab $GMAB #AbbVie $ABBV #Epcoritamab #Epkinly #ICML2025"
@EgidiusLambrech Avatar @EgidiusLambrech on X 2025-06-19 09:39:08 UTC XXX followers, 1108 engagements

creator/x::EgidiusLambrech
/creator/x::EgidiusLambrech